|
|
|
|
LEADER |
01241nai a2200277 u 4500 |
001 |
EB002001689 |
003 |
EBX01000000000000001164590 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
020 |
|
|
|a 9781473139428
|
245 |
0 |
0 |
|a COVID-19 rapid guideline: Vitamin D.
|h Elektronische Ressource
|
246 |
3 |
1 |
|a Vitamin D
|
260 |
|
|
|a London
|b National Institute for Health and Care Excellence
|c 2020, 2020 Dec. 17-
|
300 |
|
|
|a 1 online resource
|
310 |
|
|
|a Continuously updated
|
710 |
2 |
|
|a National Institute for Health and Care Excellence (Great Britain)
|
710 |
2 |
|
|a Great Britain
|b Scientific Advisory Committee on Nutrition
|
710 |
2 |
|
|a Public Health England
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
362 |
0 |
|
|a Began in 2020
|
490 |
0 |
|
|a NICE guideline
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK566063
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a This guideline covers vitamin D use in the context of COVID-19. It is for adults, young people and children in hospitals and community settings. Vitamin D is important for bone and muscle health. It may also have a role in the body's immune response to respiratory viruses
|